Articles tagged with: Multiple Myeloma Research Foundation
NewsFlash »
European Commission Grants Marketing Authorization For Mozobil – On August 5, the European Commission granted marketing authorization for Mozobil in the European Union. Access to Mozobil will allow multiple myeloma patients who require a stem cell transplant a new option. The drug is used in combination with a granulocyte-colony stimulating factor which stimulates bone marrow, and together they increase the mobilization of stem cells to the bloodstream for collection and use in stem cell transplants. Mozobil was approved in December 2008 in the United States. For more information, please see the Genzyme press release.
Sausalito Music Fan’s Bike Ride To Saratoga To Raise Money For MMRF – Cathy Gellis will be riding her bike from Sausalito, CA, to Saratoga, CA, to raise funds for the Multiple Myeloma Research Foundation (MMRF) and to see Huey Lewis and the News on August 15. She is riding in memory of Ron Stallings, a band member of the band who passed away earlier this year after being diagnosed with multiple myeloma. For more information or to make a donation, please visit Cathy’s page on the MMRF Web site.
Prairie Pedal For Myeloma – The Prairie Pedal for Myeloma blog is written by Shane Saunderson. It follows his bike ride from Calgary to Toronto to raise funds for Myeloma Canada and the Molly and David Bloom Chair in Multiple Myeloma Research. His goal is to ride 3500 km in 35 days and to raise $35,000. Shane began his ride on August 1. To follow the blog or make a donation, please visit the Prairie Pedal for Myeloma Canada Web site.
For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.
News»
For the first time, researchers have sequenced the full multiple myeloma genome.
Sequencing the full multiple myeloma genome enables scientists to discover which genes are present in a myeloma tumor, as well as to determine which genetic regions may harbor mutations. This knowledge will help researchers better understand both myeloma’s development -- how normal plasma cells in the bone marrow transform into cancerous ones – and new, tailored targets for attacking the disease.
This genetic reconstruction project by the Multiple Myeloma Genomics Initiative, which is spearheaded by the Multiple Myeloma Research Consortium …
NewsFlash »
Fill The House For LLS – On July 1, the Cleveland Indians baseball team is sponsoring a fundraiser event that will benefit the Leukemia & Lymphoma Society (LLS). This event will take place at Progressive Field at 7 p.m, and the tickets will cost $16 if purchased from the LLS, otherwise $22. The Indians will donate $5 for each ticket sold by the LLS and $1 for every other ticket purchased. For more information or to purchase tickets, please visit the LLS Web site.
Institutional Insights – On July 23, this educational program sponsored by the Multiple Myeloma Research Foundation (MMRF) will take place at The Westin Copley Place in Boston. The program will take place from 10:30 a.m. to 2 p.m. Topics to be discussed at the program include advances in diagnosis, frontline therapy, stem cell transplant, managing relapse and bone disease, as well as supportive care. For more information, please visit the MMRF Web site.
BiovaxID Vaccine Released in Europe - BiovaxID is a vaccine with the potential to treat B-cell blood cancers, such as multiple myeloma. BioVest International released this vaccine, currently used for follicular non-Hodgkin's lymphoma, on a named-patient basis in Europe. A named-patient program allows qualifying patients to receive investigational drugs before being approved by the European Medicines Evaluation Agency. For more information, please see the BioVest press release.
For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
20th Annual Gelatin Splash – On June 11 the Leukemia & Lymphoma Society (LLS) is holding an event to raise money for blood cancer research and patient aid services. The event will be held at Banchetti by Rizzo’s in Amherst, NY and will take place from 6 p.m. to 9 p.m. In the past 19 years, the LLS has raised over $1.4 million from this event. If participating in the gelatin splash, the suggested minimum of sponsorship money is $300. If attending without participating in the gelatin splash, admission is free. For more information, please visit the LLS Web site.
Institutional Insights In Multiple Myeloma – On June 18 the Multiple Myeloma Research Foundation (MMRF) is sponsoring an educational program at the Hilton Chicago. Registration begins at 10:30 a.m., and the program lasts from 11 a.m. to 2 p.m. This program’s topics include frontline therapy, stem cell transplant, relapsed/refractory disease, supportive care, and clinical trials. Time will also be allowed for a question and answer session. For more information, please visit the MMRF Web site.
For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
MMRF Race For Research : Tri-State – The Multiple Myeloma Research Foundation (MMRF) is sponsoring a 5K race on June 7 at the New Canaan High School, in New Canaan, CT. Registration begins at 7:30 a.m. and the race start time is 9 a.m. For more information or to register, please visit the MMRF Race for Research Web site.
Emerging Therapies In Leukemia, Lymphoma And Myeloma – On June 16, a free educational teleconference focusing on these three diseases begins at noon and ends at 1:30 p.m. Eastern Time. Medical professionals who will speak include Gail J. Roboz, MD; John P. Leonard, MD; and Robert Z. Orlowski, MD, PhD. Questions are welcome during the presentation. For more information or to register, please visit The Leukemia & Lymphoma Society Web site.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.
News»
Returners Host Gaming Marathon To Benefit Multiple Myeloma – On June 5 the Returners will hold a 48-hour video gaming marathon to raise money for the Multiple Myeloma Research Foundation. The Returners are a group of video gamers who organize game marathons to raise funds for charities. For more information, please see the event announcement at the Returners Web site.
CyDex Receives Support For Melphalan Development Program - The Kansas Bioscience Authority (KBA) has awarded CyDex Pharmaceuticals $195,000 to commercialize re-formulated drugs that address limitations of existing therapies. A particular …
NewsFlash »
Ontario To Fund Use Of Velcade – On May 13, Velcade (bortezomib) was added to the list of medications covered by Cancer Care Ontario’s New Drug Funding Program. Reimbursement from the Ontario government will now be available for myeloma patients being treated with Velcade. For more information, please visit The Canadian Press or Newswire Web sites.
2nd International Congress On Leukemia-Lymphoma-Myeloma – This convention will be held from May 21 to 24 in Istanbul, Turkey. Companies attending the Congress will have their products, services, and new advances on exhibition. The Congress will help facilitate the sharing of new ideas and collaboration between companies. For more information, please visit the Congress’s Web site.
AACR Awards Centennial Medals For Distinguished Public Service – On April 19, Kathy Giusti and Nicholas Valvano were awarded the AACR Centennial Medal for Distinguished Public Service at the American Association for Cancer Research’s (AACR) 100th Annual Meeting 2009. Kathy Giusti is the founder and chief executive officer of the Multiple Myeloma Research Foundation (MMRF) and was chosen for her efforts in facilitating new drug and treatment development. Nicholas Valvano is the chief executive officer of The V Foundation, which works to promote and fundraise for cancer research. He was chosen for his outstanding leadership of the foundation. For more information, please visit the MMRF Web site.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calender.
